The Cigna Corp. Health Services business will launch a solution in 2020 for covering high cost gene therapies in which payers enroll and make monthly per member payments into a newly dedicated program that would cover the cost of gene therapy in the future if they have a member who needs treatment.
The program will be administered primarily by Cigna’s eviCore specialty medical management business, which is part of Express Scripts Holding Co.. EviCore will contract with employers, insurers, HMOs and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?